The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Carsten Nieder

Department of Internal Medicine - Division of Oncology and Palliative Medicine

Nordland Hospital

Norway

[email]@hotmail.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Internal Medicine - Division of Oncology and Palliative Medicine, Nordland Hospital, Norway. 2009 - 2010
  • Medical Department, Division of Oncology, Nordland Hospital, 8092 Bodø, Norway. 2009
  • Radiation Oncology Unit, Nordlandssykehuset HF, 8092 Bodø, Norway. 2008
  • Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany. 2001 - 2007
  • Department of Radiotherapy, University Hospital of Saarland, Homburg/Saar, Germany. 1999 - 2000
  • Department of Experimental Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. 1999

References

  1. Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases. Nieder, C., Haukland, E., Pawinski, A., Dalhaug, A. BMC. Cancer (2010) [Pubmed]
  2. Prognostic indices for brain metastases--usefulness and challenges. Nieder, C., Mehta, M.P. Radiation. Oncology. (london,. England) (2009) [Pubmed]
  3. Presentation and outcome in cancer patients with extensive spread to the brain. Nieder, C., Pawiniski, A., Dalhaug, A. BMC. Res. Notes (2009) [Pubmed]
  4. Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?. Nieder, C., Pawinski, A., Andratschke, N.H., Molls, M. Radiation. Oncology. (london,. England) (2008) [Pubmed]
  5. Evaluation of insulin-like growth factor-1 in a mouse model of long-term abdominal radiation toxicity. Nieder, C., Cai, L., Weber, W.A., Schill, S., Andratschke, N., Schwaiger, M., Molls, M. Anticancer Res. (2007) [Pubmed]
  6. Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors. Nieder, C., Grosu, A.L., Stark, S., Wiedenmann, N., Busch, R., Kneschaurek, P., Molls, M. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  7. Combined modality treatment of glioblastoma multiforme: the role of temozolomide. Nieder, C., Adam, M., Grosu, A.L. Rev. Recent. Clin. Trials (2006) [Pubmed]
  8. Acceleration of normal-tissue damage expression by early stimulation of cell proliferation in rat spinal cord. Nieder, C., Andratschke, N., Price, R.E., Kian-Ang, K. Strahlenther. Onkol (2006) [Pubmed]
  9. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Nieder, C., Grosu, A.L., Andratschke, N.H., Molls, M. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  10. Current status of angiogenesis inhibitors combined with radiation therapy. Nieder, C., Wiedenmann, N., Andratschke, N., Molls, M. Cancer Treat. Rev. (2006) [Pubmed]
  11. Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors. Nieder, C., Grosu, A.L., Astner, S., Thamm, R., Molls, M. Radiat. Oncol (2006) [Pubmed]
  12. Therapeutic options for recurrent high-grade glioma in adult patients: recent advances. Nieder, C., Adam, M., Molls, M., Grosu, A.L. Crit. Rev. Oncol. Hematol. (2006) [Pubmed]
  13. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Nieder, C., Grosu, A.L., Andratschke, N.H., Molls, M. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  14. Radiotherapy and chemotherapy for myoepithelioma of the sellar region. Nieder, C., Schneller, F., Grosu, A.L., Peschel, C., Molls, M. Strahlenther. Onkol (2005) [Pubmed]
  15. Evaluation of insulin-like growth factor-1 for prevention of radiation-induced spinal cord damage. Nieder, C., Andratschke, N., Price, R.E., Rivera, B., Kian Ang, K. Growth. Factors (2005) [Pubmed]
  16. Response monitoring by positron emission tomography during radiotherapy of a squamous cell skin carcinoma. Nieder, C., Grosu, A.L. Onkologie (2005) [Pubmed]
  17. The role of pentoxifylline as a modifier of radiation therapy. Nieder, C., Zimmermann, F.B., Adam, M., Molls, M. Cancer Treat. Rev. (2005) [Pubmed]
  18. Effects of insulin-like growth factor-1 (IGF-1) and amifostine in spinal cord reirradiation. Nieder, C., Price, R.E., Rivera, B., Andratschke, N., Ang, K.K. Strahlenther. Onkol (2005) [Pubmed]
  19. Treatment of unresectable glioblastoma multiforme. Nieder, C., Grosu, A.L., Astner, S., Molls, M. Anticancer Res. (2005) [Pubmed]
  20. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?. Nieder, C., Andratschke, N., Wiedenmann, N., Busch, R., Grosu, A.L., Molls, M. Strahlenther. Onkol (2004) [Pubmed]
  21. Brain metastases in renal cell cancer: diagnostic and therapeutic aspects. Nieder, C., Grosu, A.L., Grzadziel, A., Schlegel, J., Molls, M. Am. J. Clin. Oncol. (2004) [Pubmed]
  22. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Nieder, C., Andratschke, N., Grosu, A.L., Molls, M. Strahlenther. Onkol (2003) [Pubmed]
  23. Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review. Nieder, C., Licht, T., Andratschke, N., Peschel, C., Molls, M. Cancer Treat. Rev. (2003) [Pubmed]
  24. Report of a male patient with brain metastases from breast cancer. Nieder, C., Jost, P.J., Grosu, A.L., Peschel, C., Molls, M. Breast (2003) [Pubmed]
  25. Radiotherapy-induced lung toxicity: risk factors and prevention strategies. Nieder, C., Jeremic, B., Astner, S., Molls, M. Anticancer Res. (2003) [Pubmed]
  26. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. Nieder, C., Andratschke, N., Jeremic, B., Molls, M. Anticancer Res. (2003) [Pubmed]
  27. Cervical lymph node metastases from occult squamous cell carcinoma. Nieder, C., Ang, K.K. Curr. Treat. Options. Oncol (2002) [Pubmed]
  28. The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma. Nieder, C., Petersen, S., Petersen, C., Thames, H.D. Ann. Hematol. (2001) [Pubmed]
  29. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?. Nieder, C., Gregoire, V., Ang, K.K. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
  30. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. Nieder, C., Nestle, U., Motaref, B., Walter, K., Niewald, M., Schnabel, K. Int. J. Radiat. Oncol. Biol. Phys. (2000) [Pubmed]
  31. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme. Nieder, C., Nestle, U., Ketter, R., Kolles, H., Gentner, S.J., Steudel, W.I., Schnabel, K. Radiat. Oncol. Investig (1999) [Pubmed]
  32. Radiation myelopathy: new perspective on an old problem. Nieder, C., Ataman, F., Price, R.E., Ang, K.K. Radiat. Oncol. Investig (1999) [Pubmed]
 
WikiGenes - Universities